Hyperprogressive Disease during Anti-PD-1/PD-L1 Treatment
Exploring predictive nomogram for hyperprogressive disease during anti-PD-1/PD-L1 treatment in patients with advanced non-small cell lung cancer. Click to read
Eteläuomen Läi United States Max Microsystems Lizhi Liu Association Between Cell Signaling Technology
Source: dovepress.com